search-engine
To sponsor this category, click here | subscribe to this category RSS

Home » Archives for search-engine

No Image

What is PDUFA?

Monday, July 26th, 2010
Read the full story

Intuitive Surgical: Robotic Heart Surgery Has Growing Pains

Monday, July 5th, 2010

Intuitive Surgical ( ISRG ) is the unchallenged global leader in the emerging field of minimally invasive robotic surgery. Over the last three years, Intuitive has one of the two best performing stocks of companies listed on the Nasdaq stock exchange with a market capitalization of at least $10 billion. Only the stock of the Chinese search engine Baidu ( BIDU ) has been able to match that performance.

Read the full story

The Gov’t Controls Google’s Search Results for Your Brand. Surprised?

Wednesday, June 30th, 2010

Did you notice that lately, every time you search for a pharma brand on Google, the #1 organic result is always the NIH? Always

Read the full story

Nobody Knows You’re a Fake Patient on the Internet!

Thursday, May 27th, 2010

Last night I had the honor of hosting the #socpharm “Tweetchat” session, standing in for Eileen O’Brien (@ EileenObrien ; Siren Interactive) who is the founder and regular host of that Twitter discussion stream. One issue discussed in last night’s session was Sara Baker, a “fake” patient created by MedSeek, an eMarketing company that does work for the pharma and healthcare industries. “Meet Sara Baker,” says MedSeek on its website.

Read the full story

Should Google Allow Pharma an Exception to Its Ban on Redirect URLs? (UPDATED)

Monday, May 17th, 2010

Back in April 2009, I suggested that FDA might go after pharma marketers for using paid search redirects in Google Adwords (see ” The Next FDA Concern May be the Use of ‘Redirect’ URLs “). Such ads use visible URLs such as “flaccidmember.com” but, when clicked, lead to viagra.com or cialis.com

Read the full story

Is Your Brand a Digital Genius or a Feeble-Minded Idiot?

Tuesday, May 4th, 2010

When it comes to digital IQ, some brands are geniuses and some are feeble-minded idiots, according to the “L2 Digital IQ Index” for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories. The index was created by think tank L2 in partnership with media agency PHD Network. They evaluated pharmaceutical brands’ digital presence across four criteria: Platform (40 percent, including site effectiveness and brand translation); Off-Platform Messaging (25 percent, covering digital marketing efforts such as online and mobile advertising); Search Engine Optimization (20 percent, based on visibility on top search engines); and Social Media (15 percent, defined by presence on popular 2.0 platforms)

Read the full story

Pharma: It’s Not About You

Tuesday, April 27th, 2010

I was delighted to co-author the below article on the patient-centric approach for Med Ad News’ DotPharma eNewsletter a few weeks ago. I thought readers here might enjoy it as well: – - – - – - – - – - – - – - – - – - – - – Pharma, it’s not about you anymore Marketing and communications have fundamentally changed forever, and the pharmaceutical industry is no exception to this. Pharma communicators face new channels, new challenges, new rules, and seismic shifts in the way they reach both consumers and healthcare professionals

Read the full story

Consumer Advocates Step Up and Submit Comments to FDA Regarding Regulation of Social Media

Sunday, March 21st, 2010

The deadline has come and gone for submitting comments to docket FDA-2009-N-0441 regarding “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.” You can find ALL of the comments here at Regulations.gov and easily download MOST of them here at fdaSM.com . Unfortunately, the latter does NOT include text comments that were submitted by individuals.

Read the full story

Making Sense Out Pharma DTC Spending Trends

Tuesday, March 9th, 2010

ePharma boosters see the latest direct-to-consumer (DTC) advertising spending numbers as a positive sign that the drug industry is finally increasing its allotment to the Internet in its DTC marketing budget.

Posted in: DTC | 0 Comments »
Read the full story

Merck Says FDA Should Approve the “One-Click Rule”

Thursday, March 4th, 2010

Merck submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools ( find it here ). About 75% of Merck’s comments that specifically address FDA’s questions is devoted to an argument in favor of the “one-click rule” as it applies to space-limited digital product ads.

Read the full story